AbbVie Inc (ABBV)
167.29
-0.51
(-0.30%)
USD |
NYSE |
Apr 25, 16:00
166.25
-1.04
(-0.62%)
After-Hours: 20:00
AbbVie Market Cap: 295.51B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 295.51B |
| April 24, 2024 | 296.41B |
| April 23, 2024 | 299.49B |
| April 22, 2024 | 296.57B |
| April 19, 2024 | 293.96B |
| April 18, 2024 | 290.87B |
| April 17, 2024 | 290.14B |
| April 16, 2024 | 287.12B |
| April 15, 2024 | 285.59B |
| April 12, 2024 | 286.66B |
| April 11, 2024 | 295.92B |
| April 10, 2024 | 298.59B |
| April 09, 2024 | 300.55B |
| April 08, 2024 | 299.95B |
| April 05, 2024 | 300.30B |
| April 04, 2024 | 296.59B |
| April 03, 2024 | 313.25B |
| April 02, 2024 | 319.18B |
| April 01, 2024 | 319.31B |
| March 28, 2024 | 321.67B |
| March 27, 2024 | 318.58B |
| March 26, 2024 | 316.53B |
| March 25, 2024 | 315.37B |
| March 22, 2024 | 315.23B |
| March 21, 2024 | 313.55B |
| Date | Value |
|---|---|
| March 20, 2024 | 311.38B |
| March 19, 2024 | 317.36B |
| March 18, 2024 | 315.30B |
| March 15, 2024 | 314.22B |
| March 14, 2024 | 320.08B |
| March 13, 2024 | 317.72B |
| March 12, 2024 | 319.59B |
| March 11, 2024 | 317.31B |
| March 08, 2024 | 315.93B |
| March 07, 2024 | 318.97B |
| March 06, 2024 | 319.84B |
| March 05, 2024 | 316.48B |
| March 04, 2024 | 312.75B |
| March 01, 2024 | 316.04B |
| February 29, 2024 | 310.99B |
| February 28, 2024 | 314.43B |
| February 27, 2024 | 316.18B |
| February 26, 2024 | 315.86B |
| February 23, 2024 | 314.59B |
| February 22, 2024 | 312.22B |
| February 21, 2024 | 309.38B |
| February 20, 2024 | 310.46B |
| February 16, 2024 | 313.53B |
| February 15, 2024 | 311.94B |
| February 14, 2024 | 308.11B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
93.11B
Minimum
Aug 15 2019
321.67B
Maximum
Mar 28 2024
209.59B
Average
207.02B
Median
May 18 2021
Market Cap Benchmarks
| Amgen Inc | 144.37B |
| Immunogen Inc (DELISTED) | -- |
| Johnson & Johnson | 353.80B |
| Eli Lilly and Co | 689.18B |
| Merck & Co Inc | 331.07B |
Market Cap Related Metrics
| PE Ratio | 61.28 |
| PS Ratio | 5.462 |
| Price to Book Value | 28.52 |
| Price to Free Cash Flow | 13.45 |
| Price | 167.29 |
| Earnings Yield | 1.63% |
| Operating PE Ratio | 21.92 |
| Normalized PE Ratio | 53.53 |